Commitments and Contingencies - Litigation (Details) $ / shares in Units, $ in Millions |
1 Months Ended | ||
|---|---|---|---|
|
May 19, 2022
USD ($)
$ / shares
shares
|
Jun. 04, 2021
lawsuit
|
Mar. 31, 2021
shares
|
|
| Loss Contingencies [Line Items] | |||
| Shares subject to arbitration | 3,100,000 | ||
| Legal fees, etc. | $ | $ 0.8 | ||
| Delaware Shareholder Derivative Lawsuit [Member] | |||
| Loss Contingencies [Line Items] | |||
| Consolidated number of lawsuits | lawsuit | 3 | ||
| Pestell Employment Dispute [Member] | Former Chief Medical Officer | Settled litigation | |||
| Loss Contingencies [Line Items] | |||
| Shares issued in acquisition | 8,342,000 | ||
| Warrants to purchase common shares, shares | 7,000,000 | ||
| Term of warrants | 3 years | ||
| Exercise price of warrants, per share | $ / shares | $ 0.37 |
| X | ||||||||||
- Definition The number of shares subject to arbitration in connection with acquisition of intangible asset. No definition available.
|
| X | ||||||||||
- Definition The number of lawsuits that have been consolidated. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|